Clinical Pharmacology
Indications & Usage
NITROFURANTOIN is listed as a SUSPENSION formulation in the SUSPENSION category. Consult official FDA labeling for full prescribing information.
Administration Context
NITROFURANTOIN is administered via the ORAL route as a SUSPENSION.
Administration Protocol
Prescribing Information
Refer to official FDA labeling or institutional protocols for complete dosage and administration instructions.
Safety Profile
Contraindications & Warnings
Consult the official FDA-approved labeling for complete contraindications, warnings, precautions, and patient-specific safety information.
National Drug Registry
Product and label metadata.
Marketing Category
ANDA
Route of Administration
ORAL
National Drug Code
31722-491
Manufacturer / Labeler
Camber Pharmaceuticals, Inc.
Dosage Form
SUSPENSION
Strength
See labeling
Application Number
ANDA219495
SPL Identifier
3c3bf8e0-5135-f295-e063-6294a90a7f67
WHO Regulatory Intelligence
Vaccine Safety Information
Access evidence-based safety data and clinical guidelines from global health resources.